News

Healthcare is a field where precision is non-negotiable. One area where accuracy critically matters is medication administration. Lapses in this area can lead to medication errors, potentially causing severe patient harm or even fatal outcomes.

The U.S. is currently experiencing a significant increase in drug shortages, reaching a decade-high with 323 active shortages in the first quarter of 2024. These shortages primarily affect generic sterile injectable medicines like various types of insulin due to factors like economic pressures, manufacturing complexities, and supply chain vulnerabilities​.

In recent years, supply chain problems have significantly impacted many industries, including the pharmaceutical sector. Addressing these challenges is essential, as the pharmaceutical supply chain is a critical component of patient care.

Carboplatin, a crucial chemotherapy drug widely used in the United States and globally, has been pivotal in the treatment regimens of a wide array of cancers, including ovarian, lung, and breast cancer. Its unique efficacy in chemotherapy cycles has helped countless patients improve their lives after a cancer diagnosis.

A CDMO (Contract Development and Manufacturing Organization) is a company that provides comprehensive services from drug development through drug manufacturing for pharmaceutical and biotech firms. They are revolutionizing the pharma industry by streamlining the drug development and manufacturing process, enabling faster, more efficient, and cost-effective production of pharmaceutical products.

The landscape of healthcare in the United States often feels as intricate and complicated as the human body itself. In recent times, one of the greatest challenges stirring concern among professionals and patients alike has been the drug shortages of 2024. These shortages have broad-reaching implications, affecting everything from the supply chain management of pharmaceuticals to the availability of lifesaving, critical drugs for patients in need.

Much has changed and continues to evolve in clinical trials since the advent of artificial intelligence. Artificial intelligence (AI) — the simulation of human intelligence in machines — has become an instrumental force in modern healthcare. It is rapidly transforming the landscape of clinical research, especially in the processes related to clinical trials.

In the fast-paced consumer goods industry, one innovation is quietly reshaping how we think about packaging: Smart Packaging. Smart packaging integrates science and technology to create packaging solutions that use digital identifiers to monitor product quality and track a package’s journey.

Prescription drug manufacturers often produce medications on a large scale. Pharmaceutical repackagers then acquire these medications in bulk and repackage them for distribution across diverse pharmacy markets within the healthcare industry.